BioSpace News Archive

Elevar Therapeutics, Inc. (“Elevar”), today announced the extension of its senior leadership team with the appointments of Jeff Heckman as Vice President of Project Management, Heidi Krenz, M.D. as Vice President of Drug Safety and Pharmacovigilance, Amit Pande, M.D., as Vice President of Clinical Development, and Wade Smith as Vice President of Finance.

Firma Clinical Research promoted Jennifer Mintz to Chief Commercial Officer to oversee business development, marketing, contracts and proposals.

PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Needle-free Injection System (NFIS) will be used in a clinical trial to deliver a booster vaccine against COVID-19 virus variants.

High demand for electronic skin in the healthcare sector to treat diabetes and cardiology diseases is driving market growth.

Rising prevalence of respiratory diseases and need to take precautions due to concerns related to asthma and COPD patients being more susceptible to coronavirus are factors driving market growth.

According to Emergen Research, the global wound care market size was USD 19.72 Billion in 2019 and is expected to reach USD 28.15 Billion in 2027 and register a revenue CAGR of 4.5% during the forecast period, 2020-2027.

Dynamic Infusion Therapy, LLC (“DIT”), a longstanding provider of outsourced vascular access services, has announced that it has acquired Ohio-based AccessRN.

Kubota Vision Inc. (“Kubota Vision” or the “Company”), a clinical-stage specialty ophthalmology company and a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that on January 17, 2022, the first patient has enrolled and completed the first visit in a prospective study in Japan using our Patient Based Ophthalmology Suite (PBOS), in-home optical coherence tomography (OCT*1) device.

City of Hope, and CytoImmune Therapeutics, today announced a study published in the high-impact journal Gastroenterology that demonstrates off-the-shelf anti-prostate stem cell antigen (PSCA) chimeric antigen receptor (CAR) NK cells significantly suppressed pancreatic cancer in vitro and in vivo using a method known as freeze-thaw.

According to Emergen Research, the global mice model market size was USD 1.30 billion in 2020 and is expected to reach USD 2.13 billion in 2028 and register a revenue CAGR of 6.8% during the forecast period, 2021-2028.